Future studies should delineate how HIV utilizes the IFI16/cGAS-STING signaling and other factors involved in immune impairment and explore whether modulating the pathway can serve as a viable strategy to counteract immune suppression in HIV infection, both in untreated and ART treated individuals. Here, IFI16 is linked to HIV infectious disease.